製品の概要

  • 製品名Anti-WDR49 antibody
    WDR49 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to WDR49
  • アプリケーション適用あり: IHC-P, WBmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Synthetic peptide conjugated to KLH, corresponding to a region within C terminal amino acids 553-583 of Human WDR49 (NP_849146.1).

  • ポジティブ・コントロール
    • K562 cell line lysates and Human skeletal muscle.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
  • バッファーPreservative: 0.09% Sodium Azide
    Constituents: PBS
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • 特記事項(精製)Purified through a protein A column, followed by peptide affinity purification.
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab108097 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-P 1/50 - 1/100.
WB 1/100 - 1/500. Predicted molecular weight: 79 kDa.

ターゲット情報

  • 関連性WDR49 contains 8 WD repeats. The exact function of WDR49 remains unknown. There are two named isoforms.
  • 参照データベース
  • 別名
    • FLJ33620 antibody
    • WD repeat containing protein 49 antibody
    • WD repeat domain 49 antibody
    • WDR 49 antibody

Anti-WDR49 antibody 画像

  • Anti-WDR49 antibody (ab108097) at 1/100 dilution + K562 cell line lysates at 35 µg

    Predicted band size : 79 kDa
  • Immunohistochemistry analysis in formalin fixed and paraffin embedded Human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining, ab108097 at 1/50 .

Anti-WDR49 antibody (ab108097) 使用論文

ab108097 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab108097.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"